TDOC - Teladoc Health, Inc.
NEXT EARNINGS:
Feb 25, 2026
(today)
EPS Est: $-0.19
|
Rev Est: $635.3M
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$8.17
DETAILS
HIGH:
$8.50
LOW:
$8.00
MEDIAN:
$8.00
CONSENSUS:
$8.17
UPSIDE:
79.96%
Market Cap:
805.73M
Volume:
3,803,566
Avg Volume:
5,651,310
52 Week Range:
4.4-11.9
Sector:
Healthcare
Industry:
Medical - Healthcare Information Services
Beta:
2.14
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
4,620
IPO Date:
2015-06-30
EPS (TTM):
-5.87
P/E Ratio:
-1.55
Revenue (TTM):
2.57B
Total Assets:
3.52B
Total Debt:
1.58B
Cash & Equiv:
1.30B
Rev Growth (5Y):
35.9%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
71.6%
ROCE:
-8.1%
Debt/Equity:
1.06
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-10-29 | $-0.21 | $-0.26 | +19.2% | $626.4M | $635.3M | -1.4% |
| 2025-07-29 | $-0.19 | $-0.27 | +29.6% | $631.9M | $627.7M | +0.7% |
| 2025-04-30 | $-0.19 | $-0.33 | +42.4% | $629.4M | $619.2M | +1.6% |
| 2025-02-26 | $-0.28 | $-0.21 | -33.3% | $640.5M | $639.4M | +0.2% |
| 2024-10-30 | $-0.19 | $-0.29 | +34.5% | $640.5M | $640.4M | 0.0% |
| 2024-07-31 | $-0.28 | $-0.36 | +22.2% | $642.4M | $649.6M | -1.1% |
| 2024-04-25 | $-0.49 | $-0.47 | -4.3% | $646.1M | $637.3M | +1.4% |
| 2024-02-20 | $-0.17 | $-0.22 | +22.7% | $660.5M | $671.4M | -1.6% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.57B | 2.60B | 2.41B | 2.03B | 1.09B | 553.31M | 417.91M | 233.28M | 123.16M | 77.38M | 43.53M | 19.91M |
| Net Income | (1.00B) | (220.37M) | (13.66B) | (428.79M) | (485.14M) | (98.86M) | (97.08M) | (106.78M) | (74.22M) | (58.02M) | (17.04M) | (6.02M) |
| EPS | -5.87 | -1.36 | -84.60 | -2.73 | -5.36 | -1.38 | -1.47 | -1.93 | -1.75 | -2.91 | -0.62 | -0.22 |
| Total Assets | 3.52B | 4.39B | 4.70B | 17.73B | 17.76B | 1.60B | 1.53B | 824.39M | 303.67M | 229.74M | 92.01M | 27.39M |
| Total Debt | 1.58B | 1.59B | 1.59B | 1.28B | 1.48B | 470.49M | 414.68M | 207.37M | 44.42M | 26.48M | 26.03M | 3.00M |
| Cash & Equivalents | 1.30B | 1.12B | 918.18M | 893.48M | 733.32M | 514.35M | 423.99M | 42.82M | 50.02M | 55.07M | 46.44M | 3.21M |
| Operating Cash Flow | 293.68M | 350.02M | 189.29M | 193.99M | (53.51M) | 29.87M | (4.86M) | (34.44M) | (51.80M) | (47.18M) | (11.36M) | (6.05M) |
| Free Cash Flow | 282.89M | 193.67M | 172.81M | 185.46M | (79.55M) | 18.97M | (13.27M) | (39.96M) | (55.21M) | (55.00M) | (13.09M) | (7.35M) |
| FCF per Share | 1.66 | 1.19 | 1.07 | 1.18 | -0.88 | 0.26 | -0.20 | -0.72 | -1.30 | -2.76 | -0.47 | -0.27 |
| Book Value | 1.49B | 2.33B | 2.31B | 16.05B | 15.88B | 1.01B | 1.01B | 558.90M | 230.87M | 178.56M | 53.23M | 19.05M |
| Cash & ST Investments | 1.30B | 1.12B | 918.18M | 896.02M | 786.57M | 517.06M | 478.53M | 122.31M | 65.81M | 137.35M | 46.44M | 3.21M |
| ROC Equity | -0.67 | -0.09 | -5.92 | -0.03 | -0.03 | -0.10 | -0.10 | -0.19 | -0.32 | -0.32 | -0.32 | -0.32 |